Prognostic Stage 2 Breast Cancer AJCC v8 Completed Phase Trials for Regadenoson (DB06213)

Also known as: Prognostic Stage II Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0140767 (Prognostic Stage 2 Breast Cancer AJCC v8)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03505736Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer